We are live on ! Find out more
AIM

Aigen Investment Management Portfolio holdings

AUM $389M
1-Year Est. Return 16.77%
This Fund
S&P 500
This Quarter Est. Return
-3.1%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$55.2M
Cap. Flow
+$68.6M
Cap. Flow %
13.33%
Top 10 Hldgs %
9.21%
Holding
1,071
New
432
Increased
168
Reduced
133
Closed
338

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$5.06M
2
BMY icon
Bristol-Myers Squibb
BMY
+$4.91M
3
AZO icon
AutoZone
AZO
+$4.44M
4
PSX icon
Phillips 66
PSX
+$4.04M
5
RTX icon
RTX Corp
RTX
+$3.95M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.63M
2
AWK icon
American Water Works
AWK
+$4.76M
3
ROST icon
Ross Stores
ROST
+$4.03M
4
LIN icon
Linde
LIN
+$3.44M
5
AAPL icon
Apple
AAPL
+$3.19M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.15%
2 Technology 15.58%
3 Industrials 13.47%
4 Financials 11.94%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
976
Regeneron Pharmaceuticals
REGN
$80.8B
– –
-523
Closed -$503K
RIO icon
977
Rio Tinto
RIO
$164B
– –
-16,265
Closed -$1.04M
RIVN icon
978
Rivian
RIVN
$23.2B
– –
-60,112
Closed -$658K
ROG icon
979
Rogers Corp
ROG
$2.4B
– –
-2,711
Closed -$322K
ROST icon
980
Ross Stores
ROST
$81.9B
– –
-27,452
Closed -$4.03M
RSG icon
981
Republic Services
RSG
$65.7B
– –
-6,290
Closed -$1.2M
RUSHA icon
982
Rush Enterprises Class A
RUSHA
$6.22B
– –
-6,179
Closed -$331K
RXRX icon
983
Recursion Pharmaceuticals
RXRX
$1.73B
– –
-32,812
Closed -$327K
RYTM icon
984
Rhythm Pharmaceuticals
RYTM
$7.96B
– –
-6,479
Closed -$281K
SANM icon
985
Sanmina
SANM
$10.9B
– –
-8,043
Closed -$500K
SCHW
986
Charles Schwab
SCHW
$187B
– –
-4,719
Closed -$341K
SCI icon
987
Service Corp International
SCI
$11.6B
– –
-14,790
Closed -$1.1M
SEDG icon
988
SolarEdge
SEDG
$1.95B
– –
-4,837
Closed -$343K
SFM icon
989
Sprouts Farmers Market
SFM
$8.01B
– –
-15,616
Closed -$1.01M
SHW icon
990
Sherwin-Williams
SHW
$89.8B
– –
-5,895
Closed -$2.05M
SIRI icon
991
SiriusXM
SIRI
$10.1B
– –
-13,775
Closed -$534K
SNAP icon
992
Snap
SNAP
$9.01B
– –
-37,514
Closed -$431K
SNDR icon
993
Schneider National
SNDR
$6.25B
– –
-10,352
Closed -$234K
SNOW icon
994
Snowflake
SNOW
$115B
– –
-5,181
Closed -$837K
SNV
995
DELISTED
Synovus
SNV
– –
-15,745
Closed -$631K
SPGI icon
996
S&P Global
SPGI
$120B
– –
-902
Closed -$384K
SRE icon
997
Sempra
SRE
$54.8B
– –
-4,015
Closed -$288K
SSP icon
998
E.W. Scripps
SSP
$304M
– –
-17,317
Closed -$68.1K
STM icon
999
STMicroelectronics
STM
$50B
– –
-4,965
Closed -$215K
STT icon
1000
State Street
STT
$50.7B
– –
-6,424
Closed -$497K
38 39
40
41 42

Similar funds

SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
SI
Schusterman Interests Tulsa, Oklahoma $391M AUM 33.81% 1-Year Est. Return
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Aigen Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Aigen Investment Management held 1,071 positions worth $514M, up 12% from $459M the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Aigen Investment Management deployed $68.6M of net new capital in Q2 2024, opening 432 new positions and adding to 168 existing holdings. Its largest new stake was Visa: 18,454 shares worth $4.84M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Hess, an estimated $2.91M trimmed.

  • Aigen Investment Management's largest Q2 2024 buy was Visa: 18,454 shares worth $4.84M.
  • Aigen Investment Management added most to Bristol-Myers Squibb in Q2 2024, an estimated $4.91M increase.
  • Aigen Investment Management's biggest Q2 2024 reduction was Hess, cutting an estimated $2.91M.
  • Aigen Investment Management fully exited Eli Lilly in Q2 2024, selling an estimated $6.63M.
  • Aigen Investment Management's ten largest holdings make up 9.2% of its $514M portfolio in Q2 2024.
  • Aigen Investment Management opened 432 new positions and closed 338 in Q2 2024.
  • Aigen Investment Management's portfolio value rose 12% quarter-over-quarter to $514M.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.